Alice Ossoli Selected Research

Lipoproteins (Lipoprotein)

7/2023	Abnormal Lipoproteins Trigger Oxidative Stress-Mediated Apoptosis of Renal Cells in LCAT Deficiency.
1/2023	Genetically determined deficiency of ANGPTL3 does not alter HDL ability to preserve endothelial homeostasis.
1/2022	HDL metabolism and functions impacting on cell cholesterol homeostasis are specifically altered in patients with abdominal aortic aneurysm.
1/2022	Plasma FA composition in familial LCAT deficiency indicates SOAT2-derived cholesteryl ester formation in humans.
1/2019	Dysfunctional HDL as a Therapeutic Target for Atherosclerosis Prevention.
1/2016	[Lecithin:Cholesterol Acyltransferase Deficiency, from genes to therapy].
8/2014	LCAT deficiency does not impair amyloid metabolism in APP/PS1 mice.
11/2013	Recombinant human LCAT normalizes plasma lipoprotein profile in LCAT deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alice Ossoli Research Topics

Disease

12	Lecithin Cholesterol Acyltransferase Deficiency (Lecithin:Cholesterol Acyltransferase Deficiency) 07/2023 - 11/2013
8	Atherosclerosis 02/2022 - 09/2015
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 01/2018
4	Dyslipidemias (Dyslipidemia) 06/2023 - 01/2016
3	Chronic Renal Insufficiency 06/2023 - 07/2020
2	Inflammation (Inflammations) 09/2022 - 01/2022
2	Neoplasms (Cancer) 05/2022 - 01/2022
2	Kidney Diseases (Kidney Disease) 01/2021 - 01/2021
2	Myocardial Infarction 01/2021 - 02/2013
2	ST Elevation Myocardial Infarction 01/2019 - 10/2013
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2023
1	Type 2 Diabetes Mellitus (MODY) 10/2023
1	Renal Insufficiency (Renal Failure) 07/2023
1	Inborn Genetic Diseases (Disease, Hereditary) 07/2023
1	2 Familial Hypobetalipoproteinemia 01/2023
1	Obesity 09/2022
1	Cholesteryl Ester Transfer Protein Deficiency 09/2022
1	Prostatic Neoplasms (Prostate Cancer) 05/2022
1	Abdominal Aortic Aneurysm 01/2022
1	Abdominal Obesity 01/2022
1	Non-ST Elevated Myocardial Infarction 01/2021
1	Infarction (Infarctions) 01/2021
1	Albuminuria 01/2021
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 12/2019
1	Migraine Disorders (Migraine) 01/2019
1	Lipidoses 01/2019
1	Weight Gain 01/2019
1	Weight Loss (Weight Reduction) 01/2019
1	Acute Coronary Syndrome 01/2019
1	Hypercholesterolemia 10/2018
1	Atherosclerotic Plaque (Atheroma) 10/2018
1	Proteinuria 09/2018
1	Pre-Eclampsia (Preeclampsia) 09/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Coronary Disease (Coronary Heart Disease) 06/2016
1	Nephrosis 01/2016
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2015
1	Alzheimer Disease (Alzheimer's Disease) 08/2014
1	Hypoalphalipoproteinemias (Hypoalphalipoproteinemia) 11/2013
1	Venous Thrombosis (Deep-Vein Thrombosis) 02/2013
1	Pulmonary Embolism 02/2013
1	Ischemic Stroke 02/2013

Drug/Important Bio-Agent (IBA)

10	LipidsIBA 06/2023 - 01/2018
9	Phosphatidylcholine-Sterol O-Acyltransferase (Lecithin Cholesterol Acyltransferase)IBA 07/2023 - 01/2016
9	HDL LipoproteinsIBA 07/2023 - 10/2013
9	CholesterolIBA 01/2023 - 01/2016
8	Lipoproteins (Lipoprotein)IBA 07/2023 - 11/2013
7	HDL CholesterolIBA 07/2023 - 06/2016
3	Apolipoproteins E (ApoE)IBA 01/2021 - 08/2014
3	EnzymesIBA 01/2019 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2019
2	Lipoprotein-XIBA 07/2023 - 01/2016
2	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2022
2	ApolipoproteinsIBA 01/2021 - 01/2017
1	dapagliflozinIBA 10/2023
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2023
1	Air Pollutants (Pollutants, Air)IBA 12/2022
1	Particulate MatterIBA 09/2022
1	Lipase (Acid Lipase)FDA Link 09/2022
1	Hormones (Hormone)IBA 05/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 05/2022
1	oxidized low density lipoproteinIBA 05/2022
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 02/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	Apolipoproteins B (ApoB)IBA 01/2022
1	Cholesterol Ester Transfer ProteinsIBA 01/2022
1	Sterol O-Acyltransferase 2IBA 01/2022
1	N 30IBA 01/2022
1	Metalloproteases (Metalloproteinases)IBA 01/2022
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2022
1	Cholesterol Esters (Cholesteryl Esters)IBA 01/2022
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2021
1	LigandsIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	CER-001IBA 01/2021
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2021
1	LDL Receptors (LDL Receptor)IBA 12/2019
1	MicroRNAs (MicroRNA)IBA 12/2019
1	Topiramate (Topamax)FDA LinkGeneric 01/2019
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2019
1	Blood Proteins (Serum Proteins)IBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2019
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2019
1	PolyphenolsIBA 10/2018
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2018
1	Cell Adhesion MoleculesIBA 01/2017
1	Apolipoprotein A-II (Apolipoprotein A2)IBA 01/2017
1	CytokinesIBA 01/2016
1	Fenofibrate (CiL)FDA LinkGeneric 11/2015
1	Niacin (Nicotinic Acid)FDA LinkGeneric 11/2015
1	Peptides (Polypeptides)IBA 09/2015
1	Amyloid (Amyloid Fibrils)IBA 08/2014
1	Nitric Oxide Synthase (NO Synthase)IBA 10/2013
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 02/2013

Therapy/Procedure

1	Vascular Surgical Procedures 01/2022
1	Cesarean Section (Caesarean Section) 09/2018
1	Enzyme Replacement Therapy 01/2016
1	Therapeutics 01/2016